Company Profiles View a Different Company Profile
FREE PREVIEW

From Elsevier Business Intelligence
Including company and deal data plus articles from publications like IN VIVO, Start-Up, The RPM Report, and Medtech Insight.

Celgene Corp.

www.celgene.com

Most Recent Related Deals

Most Recent Related Articles

Click an article to see a free preview (15 of 141).

 
People In Brief, The Gray Sheet 11/2011

Financings Of The Fortnight Wonders If Idenix's Recent Public Offering Is A Precursor To M&A, The Pink Sheet DAILY 11/2011

Story Title, The Pink Sheet 11/2011

Cancer Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind, The Pink Sheet 11/2011

Third Quarter Earnings Wrap Up, In Brief, The Pink Sheet 10/2011

Brand/Generic Battles Over REMS Raise Constitutional Questions For FDA, The Pink Sheet 10/2011

Emerging Views On Emerging Markets: Bank of America Merrill Lynch Global Healthcare Conference, PharmAsia News 10/2011

Acetylon Pharmaceuticals Inc., In Vivo 10/2011

Aura Biosciences Prepares To Move Nano-Enabled Drug Delivery System Into The Clinic, The Pink Sheet DAILY 9/2011

Start-Up Quarterly Statistics, Q2 2011, In Vivo 9/2011

Acceleron And Celgene Expand Anemia Collaboration With Second Compound, The Pink Sheet DAILY 8/2011

Hedge Fund MSMB Offers to Buy AMAG For $381M and Thwart Proposed Allos Merger, The Pink Sheet DAILY 8/2011

In Oncology Drug Boom, Can Next-Gen Cytotoxics Fit In?, The Pink Sheet 8/2011

SymBio On Radar Of VC Firms And Small Biotechs For Tapping Japan's Specialty Market; Signs With Onconova, PharmAsia News 7/2011

Investors Balk At AMAG-Allos Proposed Marriage, The Pink Sheet DAILY 7/2011

See all 141 articles about this company

Events & Offers


Company Information Show/Hide

Parents & Subsidiaries Show/Hide